Quaker Chemical EVP Bijlani to exit Sept. 2026

Quaker Chemical Corporation (KWR) disclosed that, effective September 30, 2026, Jeewat Bijlani will no longer serve as Executive Vice President, Global Specialty and Chief Growth Officer.

Rhea-AI Filing Summary

Quaker Chemical Corporation (KWR) disclosed that, effective September 30, 2026, Jeewat Bijlani will no longer serve as Executive Vice President, Global Specialty and Chief Growth Officer. The company states that his departure is not related to any disagreement with Quaker Houghton.

Mr. Bijlani’s separation will be treated as a termination without cause for purposes of all applicable plan benefits and his employment agreement dated September 28, 2017, effective August 1, 2019. Subject to executing a customary release of claims, he will receive severance payments and benefits consistent with those described in Quaker Chemical’s Proxy Statement filed on March 31, 2026.

8-K Event Classification

2 items: 5.02, 9.01

2 items

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

Key Figures

Effective departure date: September 30, 2026 Employment agreement date: September 28, 2017 Employment agreement effective date: August 1, 2019 +2 more

5 metrics

Effective departure date September 30, 2026 Date when Jeewat Bijlani will no longer serve as EVP, Global Specialty and Chief Growth Officer

Employment agreement date September 28, 2017 Date of Bijlani Employment Agreement governing severance terms

Employment agreement effective date August 1, 2019 Effective date of Bijlani Employment Agreement

Proxy Statement filing date March 31, 2026 Proxy Statement describing severance payments and benefits

Form 8-K signature date September 8, 2026 Date Quaker Chemical executed the report

Key Terms

termination without cause, customary release of claims, Proxy Statement, Inline XBRL

4 terms

termination without cause regulatory

"Mr. Bijlani’s separation from the Company is a termination without cause"

customary release of claims regulatory

"subject to executing a customary release of claims, Mr. Bijlani will be entitled"

Proxy Statement regulatory

"consistent with those described in the Company’s Proxy Statement filed"

A proxy statement is a document companies send to shareholders ahead of a meeting that lays out the items up for a vote—like who will sit on the board, executive pay, and major corporate decisions—and provides background so shareholders can decide how to cast their votes or appoint someone to vote for them. Think of it as an agenda plus a ballot and briefing notes, important because the outcomes can change control, strategy, and value.

Inline XBRL technical

"Cover Page Interactive Data File (embedded within the Inline XBRL document)"

Inline XBRL is a file format for financial filings that embeds machine-readable data tags directly inside the human-readable report, so the same document can be read by people and parsed by software. For investors it makes extracting, comparing and verifying financial numbers faster and more reliable—like a grocery list where each item also has a barcode—reducing manual errors and speeding up analysis.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What executive leadership change did QUAKER CHEMICAL CORP (KWR) announce in this Form 8-K?

Quaker Chemical announced that, effective September 30, 2026, Jeewat Bijlani will no longer serve as Executive Vice President, Global Specialty and Chief Growth Officer. The company states his departure is not related to any disagreement between him and the company.

How is Jeewat Bijlani’s separation from QUAKER CHEMICAL CORP (KWR) classified?

The company classifies Jeewat Bijlani’s separation as a termination without cause for purposes of all applicable plan benefits and contractual entitlements under his employment agreement and relevant company plans and programs.

What severance benefits will Jeewat Bijlani receive from QUAKER CHEMICAL CORP (KWR)?

Subject to executing a customary release of claims, Jeewat Bijlani will receive severance payments and benefits under his employment agreement and company plans, consistent with those described in the Proxy Statement filed March 31, 2026. Specific amounts are not detailed here.

Is Jeewat Bijlani’s departure from QUAKER CHEMICAL CORP (KWR) due to a disagreement with the company?

No. Quaker Chemical states that Mr. Bijlani’s departure is not related to any disagreement between him and the company. It is characterized as a termination without cause under applicable agreements and plans.

When did QUAKER CHEMICAL CORP (KWR) sign Jeewat Bijlani’s employment agreement referenced in the 8-K?

The referenced employment agreement for Jeewat Bijlani is dated September 28, 2017 and became effective August 1, 2019. Severance payments and benefits in connection with his separation will be provided under this agreement and applicable company plans.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/08/2026 - 04:34 PM EDT Accepted by SEC EDGAR 09/08/2026 - 04:34 PM EDT Learn about SEC filing dates

0000081362FALSE00000813622026-09-042026-09-04

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

September 4, 2026

Date of Report (Date of earliest event reported)

QUAKER CHEMICAL CORPORATION

(Exact name of registrant as specified in its charter)

Commission File Number 001-12019

Pennsylvania			23-0993790
(State or other jurisdiction of incorporation)			(I.R.S. Employer Identification No.)

901 E. Hector Street

Conshohocken, Pennsylvania 19428

(Address of principal executive offices)

(Zip Code)

(610) 832-4000

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $1 par value

KWR

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

INFORMATION TO BE INCLUDED IN THE REPORT

Item 5.02.    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Effective as of September 30, 2026, Jeewat Bijlani will no longer serve as Executive Vice President, Global Specialty and Chief Growth Officer of Quaker Chemical Corporation (“Quaker Houghton” or the “Company”). Mr. Bijlani’s departure is not related to any disagreement between him and the Company. Mr. Bijlani’s separation from the Company is a termination without cause for purposes of all applicable plan benefits and contractual entitlements, including his employment agreement dated September 28, 2017, effective August 1, 2019 (the “Bijlani Employment Agreement”).

In connection with the termination, subject to executing a customary release of claims, Mr. Bijlani will be entitled to receive severance payments and benefits under the Bijlani Employment Agreement and the Company’s plans and programs consistent with those described in the Company’s Proxy Statement filed with the Securities and Exchange Commission on March 31, 2026.

Item 9.01 Financial Statements and Exhibits.

The following exhibits are included as part of this Current Report on Form 8-K.

Exhibit Number						Description of Exhibit
104						Cover Page Interactive Data File (embedded within the Inline XBRL document)

-2-

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			QUAKER CHEMICAL CORPORATION
Date: September 8, 2026			By:			/s/ ROBERT T. TRAUB
						Robert T. Traub
						Senior Vice President, General Counsel and Corporate Secretary

3

Filing Exhibits & Attachments

3 documents

Other Documents

• EX-101 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 1.7 KB
• EX-101 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT 21.1 KB
• EX-101 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT 12.2 KB